Delta Variant in the COVID-19 Pandemic: A Comparative Study on Clinical Outcomes Based on Vaccination Status.

Damiana Maria Vulturar Liviu-Ștefan Moacă Maria-Adriana Neag Andrei Otto Mitre Teodora Gabriela AlexescuDiana GhermanIulia FăgărășanIoana Maria ChețanClaudia Diana GhermanOana-Elena MelinteAntigona Carmen Trofor Doina Adina Todea

Published in: Journal of personalized medicine (2024)

Our findings underscore the substantial efficacy of the vaccine in diminishing the incidence of severe disease, lowering the rates of ICU admissions, and mitigating mortality among hospitalized patients.

Keyphrases

risk factors
intensive care unit
cardiovascular events
early onset
mechanical ventilation
type diabetes
coronary artery disease
extracorporeal membrane oxygenation